IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,435,824 | +109.4% | 37,401 | +2.9% | 0.00% | +200.0% |
Q2 2023 | $685,535 | -40.6% | 36,342 | -51.1% | 0.00% | -66.7% |
Q1 2023 | $1,153,510 | +185.3% | 74,372 | +226.5% | 0.00% | +200.0% |
Q4 2022 | $404,328 | +270.9% | 22,779 | +16.4% | 0.00% | – |
Q3 2022 | $109,000 | +91.2% | 19,572 | +34.7% | 0.00% | – |
Q2 2022 | $57,000 | – | 14,532 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |